title: Obliterative bronchiolitis.
authors.affiliation: From the Division of Pulmonary and Critical Care, Department of Medicine, Oregon Health and Science University, Portland (A.F.B.); Service de Pneumologie; Assistance Publique-Hôpitaux de Paris, Hôpital Saint Louis, Paris (A.B.); Division of Pulmonary and Critical Care Medicine, Department of Medicine, New York University School of Medicine, New York (W.N.R.); and Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, Department of Medicine, University of Minnesota, Minneapolis (M.I.H.).
authors.forename: Alan F
authors.initials: AF
authors.lastname: Barker
authors.forename: Anne
authors.initials: A
authors.lastname: Bergeron
authors.forename: William N
authors.initials: WN
authors.lastname: Rom
authors.forename: Marshall I
authors.initials: MI
authors.lastname: Hertz
mesh_terms: D001989:Bronchiolitis Obliterans / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016040:Lung Transplantation / Q000009:adverse effects*; D009784:Occupational Diseases / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D011379:Prognosis
chemical_list: D007166:Immunosuppressive Agents